Benefit Dinner

You’re invited!


The 1st Annual OCWineFest Kick-off Dinner will take place Friday, November 3rd beginning at 630pm at Sun Dried Tomato Bistro in San Juan Capistrano.  The evening will not only kick-off the first annual OCWineFest (taking place Nov. 4/5 at A Stones Throw Winery) but will raise funds in support of The Leukemia & Lymphoma Society (LLS). Your support will help fund the therapies and treatments and help save lives today.

The gourmet dinner will include special wine pairings for each course, and will feature several wines from A Stones Throw Winery, Cowboy Canyon, Giracci, and Jumping Vines.  It will also honor Retired Colonel Sean Magee (USMC) in recognition of his many years of service to the Marine Corps and his commitment to charitable causes, specifically to LLS.

WHEN:  Friday November 3, 2017 – 6:30pm

WHERE:  Sun Dried Tomato Bistro, 31781 Camino Capistrano, San Juan Capistrano, CA 92675

TICKETS:   Individual tickets are $150 each. Reserve online until 11:59pm on October 30. After that, please call 714-481-5611 to reserve your space.


Silver Sponsor – $3,000 – includes Silver seating for 10 at Nov. 3rd dinner, dinner recognition, 1/2 page ad in the OCWineFest program, and 4 all-access tickets to the OCWineFest for the day of your choice.

Gold Sponsor – $5,000 – includes 10 gold seats at Nov. 3rd dinner, dinner recognition, full page ad in the OCWineFest program, 10 all-access tickets to the OCWineFest for the day of your choice. plus sponsor recognition on event banners and promotions.

Platinum Sponsor –  $10,000 – includes 10 platinum seats at dinner, dinner recognition, full page premium-placement ad in the OCWineFest program, 10 all-access tickets to the OCWineFest for the day of your choice. sponsor recognition on event banners and promotions, plus a social media promotion.

For more sponsorship information, please contact The Leukemia & Lymphoma Society at 714-481-5611 or the OCWineFest at, or call 949-300-6847 or 818-994-4661.

Background on The Leukemia & Lymphoma Society (LLS):

The Leukemia & Lymphoma Society’s continued advancements over the years, are responsible for the blood cancer survival rate doubling and tripling; in some cases, the survival rate has even quadrupled. And many LLS supported therapies not only help blood cancer patients but are now used to treat patients with rare forms of stomach and skin cancers. They’re even being tested in clinical trials for patients with a range of cancers including lung, brain, breast, pancreatic and prostate cancers. LLS funded drugs are now being tested for patients with other non-cancerous diseases like Diabetes, Rheumatoid Arthritis and Multiple Sclerosis. And most recently the first-ever immunotherapy approval by the U.S. Food and Drug Administration (FDA) for a new cutting-edge gene therapy that reprograms a patient’s immune system to find and kill cancer cells.  LLS is really are changing the face of blood cancer!